265 related articles for article (PubMed ID: 35281080)
1. Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma.
Zhang F; Liang J; Feng D; Liu S; Wu J; Tang Y; Liu Z; Lu Y; Wang X; Wei X
Front Cell Dev Biol; 2022; 10():814735. PubMed ID: 35281080
[No Abstract] [Full Text] [Related]
2. A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma.
Liu C; Wu Z; Wang L; Yang Q; Huang J; Huang J
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292980
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Exploration of Tumor Microenvironment Modulation Based on the ESTIMATE Algorithm in Bladder Urothelial Carcinoma Microenvironment.
Chen J; Lv B; Zhan Y; Zhu K; Zhang R; Chen B; Jin Y; Li Y; Zheng J; Lin C
Front Oncol; 2022; 12():724261. PubMed ID: 35237505
[TBL] [Abstract][Full Text] [Related]
4. A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration.
Luan JC; Zeng TY; Zhang QJ; Xia DR; Cong R; Yao LY; Song LB; Zhou X; Zhou X; Chen X; Xia JD; Song NH
Cancer Cell Int; 2021 Aug; 21(1):414. PubMed ID: 34362387
[TBL] [Abstract][Full Text] [Related]
5. Characterization of an Autophagy-Immune Related Genes Score Signature and Prognostic Model and its Correlation with Immune Response for Bladder Cancer.
Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M
Cancer Manag Res; 2022; 14():67-88. PubMed ID: 35023971
[TBL] [Abstract][Full Text] [Related]
6. Integrated bioinformatics analysis identifies a Ferroptosis-related gene signature as prognosis model and potential therapeutic target of bladder cancer.
Liu Z; Du D; Zhang S
Toxicol Res (Camb); 2024 Feb; 13(1):tfae010. PubMed ID: 38292893
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.
Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720
[TBL] [Abstract][Full Text] [Related]
8. Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer.
Zhang H; Song J; Dong J; Liu Z; Lin L; Wang B; Ma Q; Ma L
Front Genet; 2021; 12():551605. PubMed ID: 33732281
[No Abstract] [Full Text] [Related]
9. Identification of tryptophan metabolism- and immune-related genes signature and prediction of immune infiltration landscape in bladder urothelial carcinoma.
Zhou G; Qin G; Zhang Z; Zhao H; Xue L
Front Immunol; 2023; 14():1283792. PubMed ID: 37954600
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer.
Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465
[TBL] [Abstract][Full Text] [Related]
11. Prediction of immune infiltration and prognosis for patients with urothelial bladder cancer based on the DNA damage repair-related genes signature.
Li T; Jiang N; Bai Y; Liu T; Zhao Z; Xu X; Zhang Y; Wei F; Sun R; Liu S; Li J; Guo H; Yang R
Heliyon; 2023 Mar; 9(3):e13661. PubMed ID: 36873527
[TBL] [Abstract][Full Text] [Related]
12. A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer.
Cai Y; Cheng Y; Wang Z; Li L; Qian Z; Xia W; Yu W
BMC Cancer; 2023 Aug; 23(1):725. PubMed ID: 37543645
[TBL] [Abstract][Full Text] [Related]
13. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
[TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular characteristics of bladder urothelial carcinoma subtypes.
Li Y; Yang K; Li K; Liu H; Zhao S; Jiao M; Fu X
J Cell Biochem; 2019 Jun; 120(6):9956-9963. PubMed ID: 30548659
[TBL] [Abstract][Full Text] [Related]
15. Identification and Quantification of Iron Metabolism Landscape on Therapy and Prognosis in Bladder Cancer.
Song X; Xin S; Zhang Y; Mao J; Duan C; Cui K; Chen L; Li F; Liu Z; Wang T; Liu J; Liu X; Song W
Front Cell Dev Biol; 2022; 10():810272. PubMed ID: 35265613
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive characterization of endoplasmic reticulum stress in bladder cancer revealing the association with tumor immune microenvironment and prognosis.
Lin Y; Li T; Li Z; Shen C; Wu Z; Zhang Z; Li Z; Yang S; Wang Z; Li P; Fu C; Guo J; Hu H
Front Genet; 2023; 14():1097179. PubMed ID: 37091788
[No Abstract] [Full Text] [Related]
17. A Novel Prognostic Signature Based on Ferroptosis-Related Genes Predicts the Prognosis of Patients With Advanced Bladder Urothelial Carcinoma.
Li X; Huang J; Chen J; Zhan Y; Zhang R; Lu E; Li C; Zhang Y; Wang Y; Li Y; Zheng J; Geng W
Front Oncol; 2021; 11():726486. PubMed ID: 34966666
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the immunological and prognostic features of bladder cancer through platinum-resistance-related genes analysis and identifying potential therapeutic target P4HB.
Xiong S; Li S; Zeng J; Nie J; Liu T; Liu X; Chen L; Fu B; Deng J; Xu S
Front Immunol; 2023; 14():1253586. PubMed ID: 37790935
[TBL] [Abstract][Full Text] [Related]
19. Analysis and identification of the necroptosis landscape on therapy and prognosis in bladder cancer.
Zhao Z; Jiang N; Zhang Y; Bai Y; Liu T; Li T; Guo H; Yang R
Front Genet; 2022; 13():919829. PubMed ID: 36246597
[TBL] [Abstract][Full Text] [Related]
20. Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis.
Xing P; Jiang Z; Liu Y
BMC Cancer; 2022 Aug; 22(1):926. PubMed ID: 36030212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
